First Clinical Experience with an Adjunctive Hemoperfusion Device Designed Specifically to Remove β₂-Microglobulin in Hemodialysis

Publisher： Karger

E-ISSN： 1421-9735|19|2|260-263

ISSN： 0253-5068

Source： Blood Purification, Vol.19, Iss.2, 2000-12, pp. : 260-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of Direct Hemoperfusion with a β₂-Microglobulin Adsorption Column on Hypercytokinemia in Rats

Blood Purification, Vol. 21, Iss. 2, 2003-02 ,pp. : 145-151

Karger

Access to resources Recommend Favorite

β2-Microglobulin

Blood Purification, Vol. 17, Iss. 1, 1999-05 ,pp. : 5-8

Karger

Access to resources Recommend Favorite

Advanced Glycation End Products and β₂-Microglobulin as Predictors of Carpal Tunnel Syndrome in Hemodialysis Patients

Blood Purification, Vol. 34, Iss. 1, 2012-06 ,pp. : 3-9

Karger

Access to resources Recommend Favorite

Ultrapure Dialysate Reduces Plasma Levels of β₂-Microglobulin and Pentosidine in Hemodialysis Patients

Blood Purification, Vol. 23, Iss. 4, 2005-10 ,pp. : 311-316

Karger

Access to resources Recommend Favorite

Analysis of β₂-Microglobulin Kinetics in Hemodialysis by a Modified Variable-Volume One-Compartment Model

Blood Purification, Vol. 19, Iss. 4, 2001-09 ,pp. : 388-394

Karger

Access to resources Recommend Favorite